Age Related Macular Degeneration Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: AFF18EDFECDBEN
Market Monitor Global

Abstracts

Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.

This report contains market size and forecasts of Age Related Macular Degeneration Treatment in Global, including the following market information:

Global Age Related Macular Degeneration Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Age Related Macular Degeneration Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Lucentis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Age Related Macular Degeneration Treatment include Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche and Kanghong Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Age Related Macular Degeneration Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Age Related Macular Degeneration Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Age Related Macular Degeneration Treatment Market Segment Percentages, by Type, 2021 (%)

• Lucentis
• Eylea
• Avastin
• Other

Global Age Related Macular Degeneration Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Age Related Macular Degeneration Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Other

Global Age Related Macular Degeneration Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Age Related Macular Degeneration Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Age Related Macular Degeneration Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Age Related Macular Degeneration Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Regeneron Pharmaceuticals
• Bayer HealthCare
• Novartis
• Roche
• Kanghong Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Age Related Macular Degeneration Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Age Related Macular Degeneration Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AGE RELATED MACULAR DEGENERATION TREATMENT OVERALL MARKET SIZE

2.1 Global Age Related Macular Degeneration Treatment Market Size: 2021 VS 2028
2.2 Global Age Related Macular Degeneration Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Age Related Macular Degeneration Treatment Players in Global Market
3.2 Top Global Age Related Macular Degeneration Treatment Companies Ranked by Revenue
3.3 Global Age Related Macular Degeneration Treatment Revenue by Companies
3.4 Top 3 and Top 5 Age Related Macular Degeneration Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Age Related Macular Degeneration Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Age Related Macular Degeneration Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Age Related Macular Degeneration Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Age Related Macular Degeneration Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Age Related Macular Degeneration Treatment Market Size Markets, 2021 & 2028
  4.1.2 Lucentis
  4.1.3 Eylea
  4.1.4 Avastin
  4.1.5 Other
4.2 By Type - Global Age Related Macular Degeneration Treatment Revenue & Forecasts
  4.2.1 By Type - Global Age Related Macular Degeneration Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Age Related Macular Degeneration Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Age Related Macular Degeneration Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Age Related Macular Degeneration Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Other
5.2 By Application - Global Age Related Macular Degeneration Treatment Revenue & Forecasts
  5.2.1 By Application - Global Age Related Macular Degeneration Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Age Related Macular Degeneration Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Age Related Macular Degeneration Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Age Related Macular Degeneration Treatment Market Size, 2021 & 2028
6.2 By Region - Global Age Related Macular Degeneration Treatment Revenue & Forecasts
  6.2.1 By Region - Global Age Related Macular Degeneration Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Age Related Macular Degeneration Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Age Related Macular Degeneration Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Age Related Macular Degeneration Treatment Revenue, 2017-2028
  6.3.2 US Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.3.3 Canada Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.3.4 Mexico Age Related Macular Degeneration Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Age Related Macular Degeneration Treatment Revenue, 2017-2028
  6.4.2 Germany Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.4.3 France Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.4.4 U.K. Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.4.5 Italy Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.4.6 Russia Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.4.8 Benelux Age Related Macular Degeneration Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Age Related Macular Degeneration Treatment Revenue, 2017-2028
  6.5.2 China Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.5.3 Japan Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.5.4 South Korea Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.5.6 India Age Related Macular Degeneration Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Age Related Macular Degeneration Treatment Revenue, 2017-2028
  6.6.2 Brazil Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.6.3 Argentina Age Related Macular Degeneration Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Age Related Macular Degeneration Treatment Revenue, 2017-2028
  6.7.2 Turkey Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.7.3 Israel Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Age Related Macular Degeneration Treatment Market Size, 2017-2028
  6.7.5 UAE Age Related Macular Degeneration Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Regeneron Pharmaceuticals
  7.1.1 Regeneron Pharmaceuticals Corporate Summary
  7.1.2 Regeneron Pharmaceuticals Business Overview
  7.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Major Product Offerings
  7.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Revenue in Global Market (2017-2022)
  7.1.5 Regeneron Pharmaceuticals Key News
7.2 Bayer HealthCare
  7.2.1 Bayer HealthCare Corporate Summary
  7.2.2 Bayer HealthCare Business Overview
  7.2.3 Bayer HealthCare Age Related Macular Degeneration Treatment Major Product Offerings
  7.2.4 Bayer HealthCare Age Related Macular Degeneration Treatment Revenue in Global Market (2017-2022)
  7.2.5 Bayer HealthCare Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Age Related Macular Degeneration Treatment Major Product Offerings
  7.3.4 Novartis Age Related Macular Degeneration Treatment Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche Age Related Macular Degeneration Treatment Major Product Offerings
  7.4.4 Roche Age Related Macular Degeneration Treatment Revenue in Global Market (2017-2022)
  7.4.5 Roche Key News
7.5 Kanghong Pharma
  7.5.1 Kanghong Pharma Corporate Summary
  7.5.2 Kanghong Pharma Business Overview
  7.5.3 Kanghong Pharma Age Related Macular Degeneration Treatment Major Product Offerings
  7.5.4 Kanghong Pharma Age Related Macular Degeneration Treatment Revenue in Global Market (2017-2022)
  7.5.5 Kanghong Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Age Related Macular Degeneration Treatment Market Opportunities & Trends in Global Market
Table 2. Age Related Macular Degeneration Treatment Market Drivers in Global Market
Table 3. Age Related Macular Degeneration Treatment Market Restraints in Global Market
Table 4. Key Players of Age Related Macular Degeneration Treatment in Global Market
Table 5. Top Age Related Macular Degeneration Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Age Related Macular Degeneration Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Age Related Macular Degeneration Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Age Related Macular Degeneration Treatment Product Type
Table 9. List of Global Tier 1 Age Related Macular Degeneration Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Age Related Macular Degeneration Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Age Related Macular Degeneration Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Age Related Macular Degeneration Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Age Related Macular Degeneration Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Age Related Macular Degeneration Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Age Related Macular Degeneration Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Age Related Macular Degeneration Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Regeneron Pharmaceuticals Corporate Summary
Table 31. Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Product Offerings
Table 32. Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Bayer HealthCare Corporate Summary
Table 34. Bayer HealthCare Age Related Macular Degeneration Treatment Product Offerings
Table 35. Bayer HealthCare Age Related Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Age Related Macular Degeneration Treatment Product Offerings
Table 38. Novartis Age Related Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Age Related Macular Degeneration Treatment Product Offerings
Table 41. Roche Age Related Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Kanghong Pharma Corporate Summary
Table 43. Kanghong Pharma Age Related Macular Degeneration Treatment Product Offerings
Table 44. Kanghong Pharma Age Related Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Age Related Macular Degeneration Treatment Segment by Type in 2021
Figure 2. Age Related Macular Degeneration Treatment Segment by Application in 2021
Figure 3. Global Age Related Macular Degeneration Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Age Related Macular Degeneration Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Age Related Macular Degeneration Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Age Related Macular Degeneration Treatment Revenue in 2021
Figure 8. By Type - Global Age Related Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Age Related Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Age Related Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Age Related Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 12. US Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Age Related Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Age Related Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 24. China Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Age Related Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Age Related Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Age Related Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer HealthCare Age Related Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Age Related Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Age Related Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Kanghong Pharma Age Related Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)